The
thyroid cancer, especially
papillary thyroid cancers are very common among population with high intake of
iodine or
iodine uptake. Even though several treatment options are available, there is still complication and side effects are still persistent. The role of signaling molecules in
cancer signaling is very vast and their significance in progression of disease was increasing which leads to mortality of the patient. The major key players are PI3K, AKT and MAP
kinase, involves in cell survival, proliferation, and inhibition of apoptosis and are the promising candidate for
cancer treatment target, several researchers focuses these molecule to treat various acute and
chronic diseases like
cancer. On the other side, various literatures propose that natural compounds derived from plant source are shown potent anticancer property against several
cancers. In our study we are looking in to one such active principle obtained from plant source, a
diterpenoid compound
kirenol, and its role
thyroid cancer. Here, we report that
kirenol role on various cellular mechanisms like induction of apoptosis, enhancing ROS indirectly by inhibiting
antioxidants, altering the signaling mechanism of cell survival and apoptosis. Our study proposes that
kirenol involved in the
cancer cell cytotoxicity by inducing apoptosis and inhibition of
cancer cell survival. Thus, targeting this signaling molecule with
kirenol definitely favors and may lead to a therapeutic modality for
thyroid cancer.